Go to content Share price: FR HOME THE GROUP BUSINESSES INVESTORS MEDIA Home > Investors > Investor calendar Investors KEY FIGURES FINANCIAL PUBLICATIONS FINANCIAL PRESS RELEASES FINANCIAL REPORTS REGULATED INFORMATION SHAREHOLDERS’ MEETING INVESTOR CALENDAR ANALYSTS STOCK MARKET SHAREHOLDERS’ CORNER CONTACT US INVESTOR CALENDAR 1 Dec 2021 Shareholders’ Meeting KEEP IN TOUCH FOLLOW-US RECEIVE OUR PRESS RELEASES SUBSCRIBE SHAREHOLDERS' CLUB JOIN © 2021 Claranova | Réalisation | Cookie Settings Legal notice Privacy Policy Sitemap Contact Credits

Go to content Share price: FR HOME THE GROUP BUSINESSES INVESTORS MEDIA Home > Investors > Key figures Investors KEY FIGURES FINANCIAL PUBLICATIONS FINANCIAL PRESS RELEASES FINANCIAL REPORTS REGULATED INFORMATION SHAREHOLDERS’ MEETING INVESTOR CALENDAR ANALYSTS STOCK MARKET SHAREHOLDERS’ CORNER KEY FIGURES €472 M Annual Revenue +21 % Growth at constant FX €34 M EBITDA . €14 M Net Result Fiscal Year 2020-2021 Based on the strong results obtained in fiscal year 2020-2021 (July 2020-June 2021), Claranova confirms its ambition to achieve revenue of €700 million and EBITDA margin in excess of 10% by fiscal year 2022-2023. This ambition is driven by the Group's ability to generate a strong and profitable growth on a continuous basis while maintaining a healthy financial structure, a lever for the Group’s future growth. Revenue (in € millions) Claranova ended FY 2020-2021 with €472 million in revenue and confirmed the growth potential of its business portfolio with a 21% increase in consolidated revenue (+14% like-for-like). Group growth remained strong during the last fiscal year within a complex health environment that was overall positive for technology companies EBITDA (in € millions) This growth was accompanied by a significant increase in operating profit which nearly doubled in FY 2020-2021, bolstered by the performances of all the Group's divisions. On that basis, Claranova's main operating performance indicator, EBITDA, rose to €34 million (+96%), or 7.2% as a percentage of revenue, up from 4.3% in the prior period. Cash flow (in € millions) The cash position continued to strengthen and stood at €90 million at the end of June 30, 2021 (+9%). Highlighting the good health of Claranova's business portfolio, this increase was driven mainly by cash flow from operations before changes in net working capital, which rose to €29 million, up from €14 million in the prior period. Net debt (in € millions) With cash and cash equivalents of €90 million and financial liabilities (excluding IFRS 16 impact) of €65 million, Claranova’s financial structure remains healthy, with net cash of €25 million up from €14 million one year earlier. SFAF Full-year results 2020 - 2021 DOWNLOAD KEEP IN TOUCH FOLLOW-US RECEIVE OUR PRESS RELEASES SUBSCRIBE SHAREHOLDERS' CLUB JOIN © 2021 Claranova | Réalisation | Cookie Settings Legal notice Privacy Policy Sitemap Contact Credits